Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > CEA-Leti Announces €1 Million from bpifrance (ex OSEO) to Speed Preclinical Development of Cancer-Detecting Nanoparticles: Grant Helps Launch NICE: France’s First Nanomedicine Consortium

Abstract:
CEA-Leti announced today €1 million in funding from bpifrance to accelerate preclinical development of a liver-cancer detection system called LipImage 815™.

CEA-Leti Announces €1 Million from bpifrance (ex OSEO) to Speed Preclinical Development of Cancer-Detecting Nanoparticles: Grant Helps Launch NICE: France’s First Nanomedicine Consortium

Grenoble, France | Posted on July 3rd, 2013

The grant, awarded through bpifrance 's Strategic Industrial Innovation (ISI) program, will accelerate the development of LipImage 815™, including production and regulatory toxicity evaluation. It also supports the launch of NICE (Nano Innovation for Cancer), the first consortium of nanomedicine stakeholders in France focused on aspects of characterization and industrialization. The consortium has been accredited by the Medicen Paris Region, a competitive cluster for innovative therapies in Ile-de-France (www.medicen.org).

Developed by Leti, LipImage 815™ is a fluorescent imaging agent based on Leti's Lipidots® platform that uses lipid nanoparticles to carry a fluorescent substance to targeted cells and improve the effectiveness of diagnosis. It will be used to test for early stages of liver cancer.

Consisting of five public and private partners and led by BioAlliance Pharma, the NICE consortium includes partners with deep expertise in the field of nanomedicine. Its mission is to build a platform to accelerate the development and industrialization of nanomedicine in France by capitalizing on the strong and complementary expertise of each partner.

In addition to Leti, the consortium includes:

- BioAlliance Pharma, developer of Livatag®, a doxorubicin nanoparticle currently in phase III clinical trial for treatment of primary liver cancer
- Nanobiotix, developer of NBTXR3, a potentiator of radiation therapy in the local treatment of cancer
- DBI, a company specialized in the production of nanomedicine pharmaceutical products
- Institut Galien Paris Sud (University Paris Sud/CNRS), which has an academic-excellence team specialized in nanoparticles research

"By bringing together a highly experienced team of specialists in various fields of nanomedicine, this program can significantly accelerate the development of an effective new tool for diagnosing liver cancer," said Laurent Malier, Leti CEO. "It also leverages Leti's achievements in the Lipidots® platform, and provides another avenue for us to bring our innovations to market."

####

About CEA-Leti
Leti is an institute of CEA, a French research-and-technology organization with activities in energy, IT, healthcare, defence and security. Leti is focused on creating value and innovation through technology transfer to its industrial partners. It is specialized in nanotechnologies and their applications, from wireless devices and systems, to biology, healthcare and photonics. NEMS and MEMS are at the core of its activities. An anchor of the MINATEC campus, CEA-Leti operates 8,000-m˛ of state-of-the-art clean room space on 200mm and 300mm wafer platforms. It employs 1,700 scientists and engineers including 320 Ph.D. students and 200 assignees from partner companies. CEA-Leti owns more than 2,200 patent families.

About bpifrance ’s Strategic Industrial Innovation (ISI) program

The Strategic Industrial Innovation program promotes the emergence of European champions. It supports ambitious, innovative collaborative projects through to industrialization, driven by innovative medium-sized companies (less than 5000 employees) and small businesses (less than 250 employees). These highly promising projects are aimed at the commercialization of products which result from technological breakthroughs and which not be possible without fostering measures from the public sector. Funding is generally in the €3-10 million range, as grants-in aid and loans which are repayable if the project is a success.

For more information, please click here

Contacts:
CEA-Leti
+33 4 38 78 02 26


Agency
+33 6 64 52 81 10


bpifrance:
Vanessa Godet
Delphine Peyrat-Stricker
Tél. : 01 41 79 84
Tél. : 06 38 81 40 00

Copyright © CEA-Leti

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iranians Present Model to Predict Photocatalytic Process in Removal of Pollutants October 30th, 2014

Production of Biocompatible Polymers in Iran October 30th, 2014

Amorphous Coordination Polymer Particles as alternative to classical nanoplatforms for nanomedicine October 30th, 2014

Nanosafety research – there’s room for improvement October 29th, 2014

Govt.-Legislation/Regulation/Funding/Policy

'Electronic skin' could improve early breast cancer detection October 29th, 2014

New solar power material converts 90 percent of captured light into heat: SunShot Project aims to make solar cost competitive October 29th, 2014

Tiny carbon nanotube pores make big impact October 29th, 2014

Microrockets fueled by water neutralize chemical and biological warfare agents October 29th, 2014

Nanomedicine

Production of Biocompatible Polymers in Iran October 30th, 2014

Amorphous Coordination Polymer Particles as alternative to classical nanoplatforms for nanomedicine October 30th, 2014

'Electronic skin' could improve early breast cancer detection October 29th, 2014

Tiny carbon nanotube pores make big impact October 29th, 2014

Announcements

Iranians Present Model to Predict Photocatalytic Process in Removal of Pollutants October 30th, 2014

Production of Biocompatible Polymers in Iran October 30th, 2014

Amorphous Coordination Polymer Particles as alternative to classical nanoplatforms for nanomedicine October 30th, 2014

Nanosafety research – there’s room for improvement October 29th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Microrockets fueled by water neutralize chemical and biological warfare agents October 29th, 2014

New nanodevice to improve cancer treatment monitoring October 27th, 2014

Special UO microscope captures defects in nanotubes: University of Oregon chemists provide a detailed view of traps that disrupt energy flow, possibly pointing toward improved charge-carrying devices October 21st, 2014

Crystallizing the DNA nanotechnology dream: Scientists have designed the first large DNA crystals with precisely prescribed depths and complex 3D features, which could create revolutionary nanodevices October 20th, 2014

Alliances/Partnerships/Distributorships

'Electronic skin' could improve early breast cancer detection October 29th, 2014

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014

IRLYNX and CEA-Leti to Streamline New CMOS-based Infrared Sensing Modules Dedicated to Human-activities Characterization October 15th, 2014

New VDMA Association "Electronics, Micro and Nano Technologies" founded: Inaugural Meeting in Frankfurt/Main, Germany October 15th, 2014

Research partnerships

Sussex physicists find simple solution for quantum technology challenge October 28th, 2014

Molecular beacons shine light on how cells 'crawl' October 27th, 2014

New evidence for an exotic, predicted superconducting state October 27th, 2014

Breakthrough in molecular electronics paves the way for DNA-based computer circuits in the future: DNA-based programmable circuits could be more sophisticated, cheaper and simpler to make October 27th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE